Valvular heart disease and cardiomyopathy: reappraisal of their interplay-Reference-Cited by-同舟云学术

Valvular heart disease and cardiomyopathy: reappraisal of their interplay

Published:2023-08-10 Issue:1 Volume:21 Page:37-50
ISSN:1759-5002
Container-title:Nature Reviews Cardiology
language:en
Short-container-title:Nat Rev Cardiol

Author:

Ajmone Marsan Nina^ORCID,Graziani Francesca,Meucci Maria Chiara^ORCID,Wu Hoi W.,Lillo Rosa,Bax Jeroen J.,Burzotta Francesco,Massetti Massimo,Jukema J. Wouter^ORCID,Crea Filippo

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.nature.com/articles/s41569-023-00911-0.pdf

Reference161 articles.

1. Vahanian, A. et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 43, 561–632 (2022).

2. Elliott, P. et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur. Heart J. 29, 270–276 (2008).

3. McKenna, W. J., Maron, B. J. & Thiene, G. Classification, epidemiology, and global burden of cardiomyopathies. Circ. Res. 121, 722–730 (2017).

4. Lancellotti, P., Zamorano, J. L. & Vannan, M. A. Imaging challenges in secondary mitral regurgitation: unsolved issues and perspectives. Circ. Cardiovasc. Imaging 7, 735–746 (2014).

5. Wigle, E. D. Cardiomyopathy: the diagnosis of hypertrophic cardiomyopathy. Heart 86, 709–714 (2001).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural and functional abnormalities of left-sided cardiac chambers in Barlow’s disease without significant mitral regurgitation;European Heart Journal - Cardiovascular Imaging;2024-05-06

2. Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis;European Heart Journal - Cardiovascular Imaging;2024-03-18